AA
ALT icon

ALPS Advisors’s Altimmune ALT Stock Holding History

ALPS Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Buy
105,881
+20,204
+24% +$85.8K ﹤0.01% 972
2025
Q4 		$309K Buy
+85,677
New +$374K ﹤0.01% 937
2024
Q4 		– Sell
-54,993
Closed -$338K – 994
2024
Q3 		$338K Sell
54,993
-311
-0.6% -$2.11K ﹤0.01% 903
2024
Q2 		$368K Buy
+55,304
New +$408K ﹤0.01% 690
2023
Q4 		– Sell
-38,878
Closed -$101K – 963
2023
Q3 		$101K Buy
38,878
+2,645
+7% +$7.59K ﹤0.01% 970
2023
Q2 		$128K Buy
36,233
+3,768
+12% +$16.9K ﹤0.01% 985
2023
Q1 		$137K Sell
32,465
-860
-3% -$10.2K ﹤0.01% 992
2022
Q4 		$548K Buy
33,325
+6,546
+24% +$73.5K ﹤0.01% 573
2022
Q3 		$342K Buy
26,779
+1,142
+4% +$16.9K ﹤0.01% 678
2022
Q2 		$300K Sell
25,637
-15,199
-37% -$93.7K ﹤0.01% 806
2022
Q1 		$249K Sell
40,836
-5,148
-11% -$37.9K ﹤0.01% 789
2021
Q4 		$421K Sell
45,984
-2,465
-5% -$26.2K ﹤0.01% 608
2021
Q3 		$548K Sell
48,449
-2,124
-4% -$25.8K 0.01% 486
2021
Q2 		$498K Sell
50,573
-16,627
-25% -$227K ﹤0.01% 517
2021
Q1 		$950K Buy
67,200
+7,725
+13% +$125K 0.01% 403
2020
Q4 		$671K Buy
+59,475
New +$701K 0.01% 441

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ALPS Advisors's ALT Position: Q1 2026 in Review

ALPS Advisors increased its Altimmune (ALT) stake by 24% in Q1 2026, buying an estimated $85.8K and bringing the position to 105,881 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #972.

ALPS Advisors first reported a position in ALT in Q4 2020 and has held it in 16 quarters since. The position peaked at $950K in Q1 2021. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • ALPS Advisors held 105,881 shares of Altimmune worth $326K as of Q1 2026.
  • ALPS Advisors bought 20,204 Altimmune shares in Q1 2026, an estimated $85.8K.
  • Altimmune made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #972 holding.
  • ALPS Advisors first reported a position in Altimmune in Q4 2020 and has held it in 16 quarters since.
  • ALPS Advisors's Altimmune position peaked at $950K in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.